Novocure
NVCR
10.71
+0.02
+0.19%
Novocure
US · NVCR
#2889 by market cap
Listed 2015
10.71
+0.02
+0.19%
Periodic snapshot; not a real-time feed.
· 2026-11-20 19:30
Recent news
-
Rating change
H.C. Wainwright Maintains Novocure(NVCR.US) With Buy Rating, Cuts Target Price to $46Market Newswire · 2026/6/18
-
Ladenburg Thalmann Maintains Novocure(NVCR.US) With Buy Rating, Raises Target Price to $31Market Newswire · 2026/11/10
-
Piper Sandler Maintains Novocure(NVCR.US) With Buy Rating, Maintains Target Price $29Market Newswire · 2026/10/26
-
Rating change
Ladenburg Thalmann & Co. Remains a Buy on NovoCure (NVCR)TipRanks · 2026/2/27
-
Rating change
J.P. Morgan Sticks to Its Hold Rating for NovoCure (NVCR)TipRanks · 2026/7/13
-
Rating change
H.C. Wainwright Maintains Novocure(NVCR.US) With Buy Rating, Maintains Target Price $46Market Newswire · 2026/7/13
-
Evercore Maintains Novocure(NVCR.US) With Buy Rating, Maintains Target Price $20Market Newswire · 2026/10/30
-
Rating change
H.C. Wainwright Maintains Novocure(NVCR.US) With Buy Rating, Raises Target Price to $52Market Newswire · 2026/7/24
-
Rating change
J.P. Morgan Maintains Novocure(NVCR.US) With Hold Rating, Cuts Target Price to $17Market Newswire · 2026/7/13
-
Rating change
Evercore Maintains Novocure(NVCR.US) With Buy Rating, Cuts Target Price to $16Market Newswire · 2026/4/6
-
Wedbush Maintains Novocure(NVCR.US) With Hold Rating, Raises Target Price to $20Market Newswire · 2026/7/24
-
Rating change
H.C. Wainwright Keeps Their Buy Rating on NovoCure (NVCR)TipRanks · 2026/4/21
-
Rating change
Wells Fargo Maintains Novocure(NVCR.US) With Hold Rating, Raises Target Price to $17Market Newswire · 2026/5/4
-
Rating change
H.C. Wainwright Maintains Novocure(NVCR.US) With Buy Rating, Maintains Target Price $49Market Newswire · 2026/4/21
-
Rating change
Piper Sandler Maintains Novocure(NVCR.US) With Buy Rating, Maintains Target Price $27Market Newswire · 2026/5/26
-
Rating change
Evercore Maintains Novocure(NVCR.US) With Buy Rating, Raises Target Price to $20Market Newswire · 2026/5/1
-
Rating change
H.C. Wainwright Maintains Novocure(NVCR.US) With Buy Rating, Maintains Target Price $48Market Newswire · 2026/5/1
-
Rating change
H.C. Wainwright Maintains Novocure(NVCR.US) With Buy Rating, Cuts Target Price to $48Market Newswire · 2026/5/1
-
Wells Fargo Maintains Novocure(NVCR.US) With Hold Rating, Cuts Target Price to $15Market Newswire · 2026/10/30
-
Rating change
H.C. Wainwright Maintains Novocure(NVCR.US) With Buy Rating, Maintains Target Price $52Market Newswire · 2026/7/24
-
Rating change
H.C. Wainwright Maintains Novocure(NVCR.US) With Buy Rating, Raises Target Price to $49Market Newswire · 2026/2/27
-
Rating change
H.C. Wainwright Maintains Novocure(NVCR.US) With Buy Rating, Raises Target Price to $47Market Newswire · 2026/2/12
-
Rating change
H.C. Wainwright Maintains Novocure(NVCR.US) With Buy Rating, Maintains Target Price $39Market Newswire · 2026/2/6
-
Rating change
Leerink Partners Maintains Novocure(NVCR.US) With Buy Rating, Cuts Target Price to $24Market Newswire · 2026/1/13
Headlines are aggregated automatically and are not independently verified or edited by our team.
Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.
Novocure discussion 0 comments